PROFILPELAJAR.COM

Mark Fishman

Mark Fishman
CitizenshipUnited States
Alma materYale College, Harvard Medical School
Known forpioneering Zebrafish research in cardiology
AwardsInstitute of Medicine member, Fellow of the American Academy of Arts and Sciences
Scientific career
FieldsMedicine, Cardiology
InstitutionsNovartis Institutes of BioMedical Research, Massachusetts General Hospital, Harvard Medical School

Mark Fishman is an American cardiologist, a professor in the Harvard Department of Stem Cell and Regenerative Biology and Chief of the Pathways Clinical Service service at the Massachusetts General Hospital for patients with complex medical disorders.[1] A researcher and clinician in cardiology, he is the previous president of the Novartis Institutes for BioMedical Research (NIBR),[2] the main research arm of Novartis Pharmaceuticals.[3]

Fishman was appointed president of the newly founded Novartis Institutes for BioMedical Research in 2002 to implement a new strategy in Novartis' global drug discovery effort.[4] He is the author of over 100 publications[5] and known for pioneering research using the zebrafish as a means of visualizing the development of the circulatory system and as a model for human disease.[6][7][8]

Education

Career

He was previously a professor of medicine at Harvard Medical School, chief of cardiology at Massachusetts General Hospital, and director of the Cardiovascular Research Center at Massachusetts General Hospital. He is a fellow of the National Academy of Arts and Sciences and a member of the National Academy of Sciences, Institute of Medicine.[9]

After being the head of Novartis’ research operation for 13 years, he decided to retire in 2016[10] and became professor at Harvard and Chief at MGH[1]

References

  1. ^ a b "Mark C. Fishman, M.D." Harvard Department Of Stem Cell And Regenerative Biology. Retrieved Oct 19, 2022.
  2. ^ "Novartis People". Archived from the original on 2015-06-01. Retrieved 2009-10-20.
  3. ^ "Novartis Corporate Fact Sheet". Archived from the original on 2011-02-02. Retrieved 2009-10-20.
  4. ^ "PRdomain.com | Novartis| Novartis steps up US research investment, opening Cambridge, Massachusetts Biomedical Research Center". Archived from the original on 2011-06-16. Retrieved 2009-10-20.
  5. ^ https://www.pubmed.gov 183 results as of 20 Oct 2009
  6. ^ Barut, Bruce A.; Zon, Leonard I. (2000). "Realizing the potential of zebrafish as a model for human disease". Physiological Genomics. 2 (2): 49–51. doi:10.1152/physiolgenomics.2000.2.2.49. PMID 11015581. S2CID 12510521.
  7. ^ "Fishman profile, Forbes.com". Jan 2002. Archived from the original on 2009-04-03.
  8. ^ "Fishman biographical sketch" (PDF). Archived from the original (PDF) on 2011-07-25. Retrieved 2009-10-20.
  9. ^ "Media" (PDF). Archived from the original (PDF) on 2011-01-03. Retrieved 2009-10-20.
  10. ^ Damian Garde (24 September 2015). "Novartis' top scientist is stepping down after 13 years, making way for a Harvard luminary". Fierce Biotech. Retrieved 13 December 2016.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.